logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Aromatase Inhibition and Breast Cancer by William R. Miller, Richard Santen ISBN 9780585444871, 9780824704124, 0585444870, 0824704126

  • SKU: EBN-1865036
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

4.6

12 reviews
Instant download (eBook) Aromatase Inhibition and Breast Cancer after payment.
Authors:William R. Miller, Richard Santen
Pages:309 pages.
Year:2001
Editon:1st
Language:english
File Size:1.97 MB
Format:pdf
ISBNS:9780585444871, 9780824704124, 0585444870, 0824704126
Categories: Ebooks

Product desciption

(Ebook) Aromatase Inhibition and Breast Cancer by William R. Miller, Richard Santen ISBN 9780585444871, 9780824704124, 0585444870, 0824704126

Presents evidence that letrozole, anastrozole, and exemestane have proven efficacy as second-line therapy and indicate increased antitumor effects and less toxicity than older aromatase inhibitors and progestins! This reference provides a state-of-the-art assessment of drugs that inhibit the synthesis of estrogens-particularly agents used to treat breast cancer-and demonstrates how the endocrinological effects of the new generation of inhibitors translate into clinical benefits. Highlights recent key research aimed at developing novel reagents and technology to optimize drug therapies and expand their clinical applications. With contributions from over 75 international experts, Aromatase Inhibition and Breast Cancer ·reviews the preclinical development of aromatase inhibitors and their place in the current practice of breast cancer management ·considers aromatase inhibitors for early stages of breast cancer as an adjuvant to surgery ·explains how machine learning techniques accurately identify tumors likely to respond to treatment ·gives an immunohistological evaluation of aromatase protein and RT-PCR measurements at the level of mRNA ·describes how model systems based on human material have optimized the use and demonstrated the potential of aromatase inhibitors ·presents the case for employing aromatase inhibitors to treat pubertal gynecomastia, prostate cancer, and benign and malignant endometrial conditions ·and more! Given the remarkable endocrine effects and the clinical potential of the new generation of aromatase inhibitors, Aromatase Inhibition and Breast Cancer is an essential reference for oncologists, endocrinologists, gynecologists, obstetricians, pharmacologists, family physicians, reproductive biologists, and medical school students in these disciplines.
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products